Home
>
National Drug Code (NDC)
>
SINGULAIR
SINGULAIR - 0006-9275-31 - (montelukast sodium)
Drug Information of SINGULAIR
| Product NDC: | 0006-9275 |
| Proprietary Name: | SINGULAIR |
| Non Proprietary Name: | montelukast sodium |
| Active Ingredient(s): | 5 mg/1 & nbsp; montelukast sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SINGULAIR
| Product NDC: | 0006-9275 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020830 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980220 |
Package Information of SINGULAIR
| Package NDC: | 0006-9275-31 |
| Package Description: | 30 TABLET, CHEWABLE in 1 BOTTLE (0006-9275-31) |
NDC Information of SINGULAIR
| NDC Code | 0006-9275-31 |
| Proprietary Name | SINGULAIR |
| Package Description | 30 TABLET, CHEWABLE in 1 BOTTLE (0006-9275-31) |
| Product NDC | 0006-9275 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | montelukast sodium |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 19980220 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | MONTELUKAST SODIUM |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |
